Chazzle,

With previous infections, vaccination and reduced virulence of omicron the incidence of severe and critical disease is undoubtedly reduced.

Reduced not eliminated.

This holds true in US, Europe and Brazil. Nonetheless, still a lot of critical illness, thus high ICU occupancy here and Brazil.

The huge number of cases is sufficient to result in many ICU admissions and opportunities for Leronlimab to save the day.